Type IV collagen high molecular form and production and diagnostic use
thereof
    2.
    发明授权
    Type IV collagen high molecular form and production and diagnostic use thereof 失效
    IV型胶原蛋白高分子形式及其生产和诊断用途

    公开(公告)号:US6060255A

    公开(公告)日:2000-05-09

    申请号:US164461

    申请日:1998-10-01

    摘要: A type IV collagen high molecular form having a higher molecular weight than the 7S domain of type IV collagen and including the 7S domain in its structure, is obtained from the supernatant being recovered from a collagen solution digested by pepsin in the following steps;1) salt precipitating with sodium chloride at a concentration no higher than 1.2 M,2) dissolving the precipitates,3) salt precipitating with sodium chloride at a concentration no higher than previous concentration. By reacting a sample with an antibody which reacts with this form, the type IV collagen high molecular form in the sample can be measured to allow diagnosis of the degree of liver fibrosis in patients with liver diseases.

    摘要翻译: 从以下步骤从胃蛋白酶消化的胶原溶液中回收的上清液获得具有比IV型胶原的7S结构域更高分子量并包含其结构的7S结构域的IV型胶原高分子形式; 1)浓度不高于1.2M的氯化钠沉淀,2)溶解沉淀物,3)以不高于先前浓度的浓度用氯化钠沉淀。 通过使样品与与该形式反应的抗体反应,可以测量样品中的IV型胶原蛋白高分子形式,以诊断肝脏疾病患者的肝纤维化程度。

    Estimation of change in bone mineral density and diagnosis of osteoporosis
    3.
    发明授权
    Estimation of change in bone mineral density and diagnosis of osteoporosis 失效
    骨矿物质密度变化和骨质疏松症诊断的估计

    公开(公告)号:US06258552B1

    公开(公告)日:2001-07-10

    申请号:US08603121

    申请日:1996-02-20

    IPC分类号: G01N3353

    CPC分类号: G01N33/6869

    摘要: A method for estimation of change in bone mineral density or a method for diagnosis of osteoporosis, comprising the step of measuring change in a concentration of soluble interleukin-6 receptor in a blood sample, by for example, sandwich assay or competition assay; and a kit for carrying out the methods, comprising: (1) an anti-sIL-6R antibody immobilized to a solid carrier, and (2) an anti-sIL-6R antibody bound to a detectable marker or capable of binding to a detectable marker.

    摘要翻译: 一种评价骨矿物质密度变化的方法或骨质疏松症诊断方法,其特征在于,包括测定血液样品中可溶性白细胞介素-6受体浓度的变化的步骤,例如,夹心测定法,竞赛法等。 以及用于进行所述方法的试剂盒,其包括:(1)固定在固体载体上的抗-SIL-6R抗体,和(2)结合可检测标记或能够结合可检测标记的抗sIL-6R抗体 标记。

    Estimation of change in bone mineral density and diagnosis of
osteoporosis
    4.
    发明授权
    Estimation of change in bone mineral density and diagnosis of osteoporosis 失效
    骨矿物质密度变化和骨质疏松症诊断的估计

    公开(公告)号:US6008005A

    公开(公告)日:1999-12-28

    申请号:US603121

    申请日:1996-02-20

    CPC分类号: G01N33/6869

    摘要: A method for estimation of change in bone mineral density or a method for diagnosis of osteoporosis, comprising the step of measuring change in a concentration of soluble interleukin-6 receptor in a blood sample, by for example, sandwich assay or competition assay; and a kit for carrying out said methods, comprising:(1) an anti-sIL-6R antibody immobilized to a solid carrier, and(2) an anti-sIL-6R antibody is bound to a detectable marker or capable of binding to a detectable marker.

    摘要翻译: 一种评价骨矿物质密度变化的方法或骨质疏松症诊断方法,其特征在于,包括测定血液样品中可溶性白细胞介素-6受体浓度的变化的步骤,例如,夹心测定法,竞赛法等。 以及用于实施所述方法的试剂盒,其包含:(1)固定在固体载体上的抗-SIL-6R抗体,和(2)抗-SIL-6R抗体与可检测标记结合或能够结合至 可检测标记。

    Measurement method and kit for hemoglobin A1c
    5.
    发明授权
    Measurement method and kit for hemoglobin A1c 失效
    血红蛋白A1c测定方法及试剂盒

    公开(公告)号:US5932480A

    公开(公告)日:1999-08-03

    申请号:US816326

    申请日:1997-03-13

    摘要: A sample containing hemoglobin A1c (HbA1c) is simultaneously brought in contact with a solid phase and anti-HbA1c antibody, the anti-HbA1c antibody bound to the adsorbed HbA1c on the solid phase and the anti-HbA1c antibody in solution are separated, and the anti-HbA1c antibody bound to the adsorbed HbA1c on the solid phase is detected. HbA1c % is determined by one-step immunoassay, and the time required for measurement is shortened in comparison with conventional immunoassay methods. Since the exposure time to the pretreatment solution present in the reaction solution during the immune reaction is shortened, formation of a precipitate in the sample as well as inactivation of the enzyme of the enzyme-labeled anti-HbA1c antibody, when used, is reduced.

    摘要翻译: 将含有血红蛋白A1c(HbA1c)的样品同时与固相和抗HbA1c抗体接触,将与固相上吸附的HbA1c结合的抗HbA1c抗体和溶液中的抗HbA1c抗体分离, 检测到与固相上吸附的HbA1c结合的抗HbA1c抗体。 HbA1c%通过一步免疫测定法测定,与常规免疫测定方法相比,测定所需的时间缩短。 由于在免疫反应中存在于反应溶液中的预处理溶液的暴露时间缩短,所以在使用时,样品中的沉淀物的形成以及酶标记的抗HbA1c抗体的酶的失活减少。